US Broker Ratings

Health Catalyst, Inc. (HCAT) Stock Analysis: A Promising 88% Potential Upside for Investors

Investors looking for a compelling opportunity in the healthcare sector may find Health Catalyst, Inc. (NASDAQ: HCAT) an intriguing prospect. With a market capitalization of $275.62..

Erasca, Inc. (ERAS) Stock Analysis: Exploring a Potential 280% Upside in Biotechnology

Erasca, Inc. (NASDAQ: ERAS) is making waves in the biotechnology sector, offering investors a compelling opportunity in the ever-evolving landscape of precision oncology. As a San..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Lucrative Opportunity with 94% Upside Potential

For investors with an eye towards biotechnology, Palvella Therapeutics, Inc. (PVLA) represents a tantalizing opportunity in the healthcare sector. With its focus on rare genetic skin..

Viemed Healthcare, Inc. (VMD) Stock Analysis: Exploring a Potential 74% Upside

Viemed Healthcare, Inc. (NASDAQ: VMD) presents an intriguing opportunity for investors looking to delve into the healthcare sector, specifically within the niche of medical devices and..

Fair Isaac Corporation (FICO) Stock Analysis: Exploring a 21.69% Potential Upside for Investors

Fair Isaac Corporation (NYSE: FICO) is a behemoth in the technology sector with a remarkable market capitalization of $43.94 billion. Renowned for its pioneering role in..

Tvardi Therapeutics, Inc. (TVRD) Investor Outlook: A 93.55% Potential Upside in Biotechnology

Tvardi Therapeutics, Inc. (TVRD) is commanding attention in the biotechnology sector with a compelling narrative for investors. Based in Sugar Land, Texas, Tvardi is a biotechnology..

Neuronetics, Inc. (STIM) Investor Outlook: Unveiling a Compelling 78.88% Potential Upside

Neuronetics, Inc. (NASDAQ: STIM) is capturing the attention of the healthcare investment community with a promising potential upside of 78.88%. This medical device company, specializing in..

Cidara Therapeutics (CDTX) Investor Outlook: A 61.97% Potential Upside in Biotech Innovation

Cidara Therapeutics, Inc. (CDTX), headquartered in San Diego, California, is a biotechnology company carving its niche in the healthcare sector by targeting serious diseases like cancer..

Senseonics Holdings, Inc. (SENS): Investor Outlook with a 196.71% Potential Upside

Senseonics Holdings, Inc. (SENS), a pioneering entity in the healthcare sector, is drawing attention with its remarkable potential upside of 196.71%. Headquartered in Germantown, Maryland, Senseonics..

ClearPoint Neuro Inc. (CLPT): Investor Outlook with a Promising 125% Upside Potential

ClearPoint Neuro Inc. (NASDAQ: CLPT) is capturing the attention of investors with its innovative approach to medical devices in the healthcare sector, particularly in the realm..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring an 84% Potential Upside in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO) is capturing investor attention with its substantial potential upside. With a market cap of $319.04 million, this California-based healthcare company operates..

Pacific Biosciences of California (PACB) Stock Analysis: Investors Eye 81% Potential Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors seeking exposure..

Spok Holdings, Inc. (SPOK) Stock Analysis: A Healthcare Communication Leader with a 20% Upside

Investors looking for opportunities in the healthcare sector may want to keep an eye on Spok Holdings, Inc. (NASDAQ: SPOK), a company that specializes in health..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: Exploring a Promising 247% Upside Potential

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is capturing investor attention with an intriguing confluence of clinical potential and financial metrics. As a clinical-stage biotechnology firm, Cartesian Therapeutics..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: A Promising Biotech with Over 500% Potential Upside

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) stands out in the biotechnology sector with a focus on developing innovative therapies for women’s cancers. Despite its current modest market..

Aura Biosciences, Inc. (AURA) Stock Analysis: A 224% Potential Upside in the Biotech Sector

Aura Biosciences, Inc. (AURA), a clinical-stage biotechnology company, is capturing attention with a striking potential upside of 224.28%. This figure, derived from the average target price..

Quhuo Limited (QH) Investor Outlook: Navigating Challenges with a 52-Week High Potential

Quhuo Limited (QH), a notable player in the gig economy space in China, presents a complex yet intriguing profile for investors keen on the technology sector...

Nerdy Inc. (NRDY) Stock Analysis: Navigating Challenges and Opportunities in the Online Learning Sector

Nerdy Inc. (NRDY), a prominent player in the online learning industry, is navigating a complex financial landscape. With a market capitalization of $331.5 million, the company..

Candel Therapeutics, Inc. (CADL): Biotechnology Innovator with a 296.83% Potential Upside

Candel Therapeutics, Inc. (NASDAQ: CADL) is capturing attention in the biotechnology sector with its ambitious clinical programs and promising potential upside. With a market capitalization of..

Sanara MedTech Inc. (SMTI) Stock Analysis: Exploring a 69.32% Potential Upside in Healthcare Innovation

Sanara MedTech Inc. (NASDAQ: SMTI) is carving out a niche within the healthcare sector, specifically in the medical instruments and supplies industry. Based in Fort Worth,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds